|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
|
|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||
| Cash | ||||||||
| Due from Sponsor | ||||||||
| Prepaid expenses | ||||||||
| Total Current Assets | ||||||||
| Long-term prepaid insurance | ||||||||
| Cash and securities held in Trust Account | ||||||||
| Total Assets | ||||||||
| Current Liabilities | ||||||||
| Accounts payable and accrued expenses | ||||||||
| Accrued offering costs | ||||||||
| Promissory note - related party | ||||||||
| Total Current Liabilities | ||||||||
| Deferred underwriting fee | ||||||||
| Total Liabilities | ||||||||
| Class A Ordinary Shares subject to possible redemption 17,250,000 shares issued and outstanding, at redemption value of $10.73 per share as of June 30, 2026 and $10.54 as of December 31, 2025 | ||||||||
| Class A Ordinary Shares | ||||||||
| Total class A Ordinary Shares subject to possible redemption 17,250,000 shares issued and outstanding, at redemption value of $10.73 per share as of June 30, 2026 and $10.54 as of December 31, 2025 | ||||||||
| Shareholders’ Deficit | ||||||||
| Ordinary shares, value | ||||||||
| Class A Ordinary Shares | ||||||||
| Class B Ordinary Shares | ||||||||
| Additional paid-in capital | ||||||||
| Accumulated deficit | ||||||||
| Total Shareholders’ Deficit | ||||||||
| TOTAL LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION, AND SHAREHOLDERS’ DEFICIT |
Loading...
